Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 31 min ago
Peer-reviewedPublisher termsThe Cochrane Database of Systematic Reviews

Levodopa or dopamine agonists for enhancing motor function after stroke

11 affiliations
  1. 1Department of Neurology and Stroke Center University Hospital of Basel Basel Switzerland
  2. 2Department of Clinical Research, Faculty of Medicine University of Bern Bern Switzerland
  3. 3Department of Health Eastern Switzerland University of Applied Sciences St Gallen Switzerland
  4. 4Pragmatic Evidence Lab, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) University Hospital of Basel and University of Basel Basel Switzerland
  5. 5Institute of Health, Midwifery and Nursing Science, Medical Faculty Martin Luther University Halle-Wittenberg Halle (Saale) Germany
  6. 6JBI Centre for Evidence-Based Healthcare Eastern Switzerland Adelaide University Adelaide Australia
  7. 7University Medical Library University of Basel Basel Switzerland
  8. 8CLEAR Methods Center, Division of Clinical Epidemiology, Department of Clinical Research University Hospital Basel, University of Basel Basel Switzerland
  9. 9Meta-Research Innovation Center at Stanford (METRICS) Stanford University Stanford California USA
  10. 10Department of Rehabilitation and Neurology University Department of Geriatric Medicine, Felix Platter Basel Switzerland
  11. 11Department of Rehabilitation and Neurology University Department of Geriatric Medicine, Felix Platter, University of Basel Basel Switzerland

Related

  1. Nonhormonal management of endometriosis: Role of dopamine D2 receptor agonists in preserving fertility and ovarian function.
    Rahi Tinni Basu, Pradip Kumar Mitra
    F&S reportsPeer-reviewedCC BY-NC-NDFull textObstetrics, gynaecology & paediatricsEurope PMC
  2. Psychiatric and Behavioral Adverse Event Reporting Patterns Among Dopamine Agonists in Parkinson’s Disease Using the Food and Drug Administration Adverse Event Reporting System
    Toru Ogura, Chihiro Shiraishi
    Psychopharmacology BulletinPeer-reviewedLicence not statedFull textPharmacology & toxicologyPMC
  3. GLP-1 Receptor Agonists, Stroke, and Cognitive Outcomes: Systematic Review and Meta-Regression
    M. Danielli, R. Sibal, G. Collett +4
    medRxivPreprintAll rights reservedFull textCardiovascular medicinemedRxiv
  4. Genetic Insights Into Protective Effects of GLP-1 Receptor Agonists on Stroke and Alzheimer Disease Across Ancestries
    Ilana Caro-Châtelier, Muralidharan Sargurupremraj, Chengran Yang +20
    Neurology GeneticsPeer-reviewedCC BY-NC-NDFull textGenetics & genomicsEpidemiology & public healthHAL
  5. GLP-1 receptor agonists counteract the detrimental effects of pasireotide on pancreatic beta-cell function and survival
    Giuseppina Biondi, Nicola Marrano, Martina Rella +16
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textSurgery & anaesthesiaCrossref
BibTeX
@article{jauslin2026levodopa,
  title = {{Levodopa or dopamine agonists for enhancing motor function after stroke}},
  author = {Andrea S Jauslin and Lukas Boos and Julian Hirt and Valerian Altersberger and Hannah Ewald and Josefin Emelie Kaufmann and Benjamin Speich and Lars G Hemkens and Christopher Traenka and Stefan T Engelter},
  journal = {The Cochrane Database of Systematic Reviews},
  year = {2026},
  month = oct,
  doi = {10.1002/14651858.cd013416.pub2},
  url = {https://doi.org/10.1002/14651858.cd013416.pub2},
}
RIS
TY  - JOUR
TI  - Levodopa or dopamine agonists for enhancing motor function after stroke
AU  - Andrea S Jauslin
AU  - Lukas Boos
AU  - Julian Hirt
AU  - Valerian Altersberger
AU  - Hannah Ewald
AU  - Josefin Emelie Kaufmann
AU  - Benjamin Speich
AU  - Lars G Hemkens
AU  - Christopher Traenka
AU  - Stefan T Engelter
PY  - 2026
DA  - 2026/10/29
JO  - The Cochrane Database of Systematic Reviews
DO  - 10.1002/14651858.cd013416.pub2
UR  - https://doi.org/10.1002/14651858.cd013416.pub2
SN  - 1469-493X
ER  -